在扩张性心肌病中,左心室逆向重塑所需的成功率和时间的最新趋势
Masahiro Wanezaki1, Tetsu Watanabe1, Atsushi Iizuka1
1Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine Yamagata Japan.
Circulation reports
|February 11, 2025
概括
在扩张性心肌病 (DCM) 中,左心室逆转型改造 (LVRR) 率正在增加,实现时间更快. 较高的β-阻断剂剂量和较低的B型性尿素 (BNP) 水平在排出时与LVRR成功有关.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭研究研究
背景情况:
- 扩张性心肌病 (DCM) 是心力衰竭的一个重要原因.
- 左心室逆转型改造 (LVRR) 是DCM患者的积极预后指标.
研究的目的:
- 调查最近的DCM案件中的LVRR实现率,LVRR的时间和相关因素.
- 分析不同时期的LVRR趋势.
主要方法:
- 对121名DCM患者的回顾性分析.
- LVRR定义为左心室喷射率≥40%与≥10%的改善.
- 多变量分析以确定与LVRR相关的因素.
主要成果:
- 68%的患者 (82/121) 实现了LVRR,平均时间为208天.
- 较高的β阻塞剂量 (OR 3.379) 和较低的排泄B型性尿素 (BNP) 水平 (OR 0.483) 独立地与LVRR相关.
- 最近的时期 (2018-2022) 与之前的时期 (2007-2017,48.4%) 相比,LVRR率显著上升 (89.5%) 和LVRR时间缩短.
结论:
- 在DCM中,LVRR实现率正在增加,LVRR的时间正在减少.
- 贝塔阻断剂治疗和放电BNP水平是影响DCM中LVRR的关键因素.
相关概念视频
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


